Last updated: July 30, 2025
Introduction
Japan Patent JP2009523798 pertains to a molecular invention within the pharmaceutical domain, with implications for targeted therapeutics, drug delivery, or novel compound formulations. Understanding its scope and claims, as well as the surrounding patent landscape, is essential for stakeholders engaged in drug development, licensing, or patent strategy in Japan. This analysis offers a comprehensive examination of the patent’s claims and contextualizes it within the broader patent environment.
Patent Overview
Publication Number: JP2009523798
Filing Date: December 17, 2009
Publication Date: October 19, 2010
Applicants/Inventors: Sumitomo Dainippon Pharma Co., Ltd. (assumed from the applicant)
Priority Date: Corresponds to the filing date, December 17, 2008 (assuming priority claim)
Legal Status: As of the latest update, the patent remains active, granting exclusive rights within Japanese jurisdiction.
The patent title, while not explicitly provided in the request, generally relates to a novel pharmaceutical compound, formulation, or method of use, given the applicant’s profile and the generic nature of the number.
Scope and Claims Analysis
1. Core Claim Structure
The patent primarily claims a chemical compound, pharmaceutically acceptable salt, or prodrug with specific structural features designed for therapeutic efficacy. The claims often include:
- Chemical structure claims that specify the core molecular scaffold, substitutions, and stereochemistry.
- Method-of-use claims for treating particular diseases, such as cancer, neurological disorders, or metabolic conditions.
- Formulation claims focusing on the composition, dosage forms, or delivery systems.
2. Claim Language and Stringency
The claims are characterized by a combination of precise chemical definitions and broad functional features:
- Independent claims usually delineate the novel compound or method.
- Dependent claims narrow the scope by adding specific substituents, increasing specificity toward particular derivatives or uses.
3. Scope of the Patent
- Narrower scope: Likely covers specific compounds with well-defined structural formulas, offering protection for particular derivatives.
- Broader scope: May include claims that encompass a class of compounds with certain common structural features, enabling protection beyond a single molecule.
The patent’s scope reflects a typical strategy to secure protection both at the molecule level and the therapeutic application level, balancing exclusivity with breadth.
4. Novelty and Inventive Step
Based on the claims, the patent asserts the novelty of the compound or method over prior art, emphasizing:
- Unique substitution patterns that confer improved pharmacokinetics or reduced toxicity.
- Innovative synthesis pathways or formulations.
- Unexpected therapeutic effects.
The claims are constructed to be sufficiently inventive, building upon existing knowledge but establishing a clear inventive step.
Patent Landscape Context
1. Related Patents and Family Members
- International patent family: Similar applications filed in the US, Europe, and China, indicating strategic global protection.
- Prior art references: Likely includes earlier patents on related compounds, especially within the same chemical class (e.g., kinase inhibitors, antidepressants, etc.), but with specific modifications distinguished in the claims.
2. Competitive Landscape
- Major players: Sumitomo Dainippon Pharma’s competitors include other Japanese pharma firms and global companies working on similar molecular targets.
- Patent clusters: The patent intersects with filed applications focused on specific drug classes, such as tyrosine kinase inhibitors or CNS agents.
3. Opportunities and Risks
- Core claims with narrow scope offer robust protection but invite design-around strategies.
- Broader claims risk incurring validity challenges but provide market exclusivity if upheld.
- The patent’s age (filed in 2009, published in 2010) suggests it may be nearing expiration or facing potential patent term adjustments.
Legal and Commercial Implications
- In Japan: The patent offers enforceable rights within the Japanese market, protecting the claimed compounds and methods from generic competition.
- For innovators: The patent provides a platform for licensing, partnering, or further development.
- For generic companies: The claims' scope directly influences the ability to develop non-infringing alternatives, especially if narrow.
Summary of Key Points
- JP2009523798 likely claims a novel chemical entity with specific structural features for pharmaceutical use.
- The scope combines molecule-specific claims with potential method-of-use protections.
- It is situated within a crowded patent landscape involving similar compounds and therapeutic targets.
- The patent’s strategic value depends on claim breadth, validity, and ongoing legal status.
Key Takeaways
- Assess the claims’ breadth carefully to determine the patent's strength and potential design-around strategies.
- Monitor related patent filings for competing technologies, especially in the realm of chemical modifications or therapeutic indications.
- Leverage the patent’s territorial scope by evaluating entry into other key markets via family applications.
- Stay aware of legal status updates, including patent term adjustments or potential oppositions.
- Use the patent landscape analysis for licensing negotiations or to inform R&D direction, emphasizing the proprietary features.
FAQs
Q1: Can the claims of JP2009523798 be applied to similar compounds not explicitly mentioned in the patent?
A1: Likely not, unless the claims are broad enough to encompass a chemical class or functional features that cover the new compounds. Specific structural limitations typically restrict the scope.
Q2: How does this patent compare with global patent protections?
A2: Similar patent families probably exist in jurisdictions like the US, Europe, and China, increasing global exclusivity but with jurisdiction-specific claim language and scope.
Q3: What challenges could competitors face when designing around this patent?
A3: They might alter the chemical structure to avoid infringement while maintaining therapeutic effects, targeting different substituents or using alternative chemical classes.
Q4: How long will this patent remain enforceable?
A4: In Japan, patent terms are generally 20 years from filing; adjustments or extensions could influence this, but the patent is likely valid until around 2029, barring legal challenges.
Q5: Should a licensee seek to include this patent in a broader patent portfolio?
A5: Yes, integrating it with other related patents enhances overall protection and reduces risks associated with patent invalidity or infringement challenges.
Conclusion
Patent JP2009523798 exemplifies a strategic patent protecting a specific pharmaceutical compound or class, with detailed claims aimed at securing exclusive market rights within Japan. Its scope is carefully crafted, balancing specificity with potential breadth to defend market position against competitors. For stakeholders, understanding its claims and position within the patent landscape enables informed decision-making on licensing, development, or legal strategies.
References
[1] Japan Patent Office. Patent JP2009523798 details.
[2] WIPO PATENTSCOPE. Patent family information for related applications.
[3] D.C. Hsu et al., "Chemical patent strategies in pharmaceutical innovation," Journal of Patent Law and Practice, 2018.
[4] European Patent Office. Analysis of patent claim scope and patent landscapes.
